Bayer Partners With Lachlan Kenya To Distribute Premium Termiticide

Bayer SouthEast Africa through its Environmental Science subdivision has partnered with Lachlan Kenya Limited, a subsidiary of Unifert, to distribute Premise 200SC, a premium termiticide targeting the building and construction industry.

The product provides a premium solution for termite control with continuous technical training support for product application.

The manufacturer guarantees five years’ effectiveness compared to the average three years for other products in the market. The product, according to the manufacturer kills the nest, where it takes one termite to eliminate the rest and low volume of product used per application.

“Termites play a vital role in nature by recycling dead and decaying wood. Unfortunately, they can’t tell the difference between dead trees and structural timbers. Termite barriers, therefore, need to be incorporated into the construction of new and existing buildings, which are vulnerable to termite infestation. Lachlan is a key player in the termiticide market in Kenya and we will integrate our termiticide offering into their established dealership network in Kenya,” said Aladji CISSE, Head of Bayer Environmental Science for Sub-Saharan Africa.

“We have been distributing termiticides in Kenya for many years and in the last few years have faced immense challenges linked to counterfeit products. We are excited to take on the distributorship of this premium product that will ensure we continue serving our clients for years to come”, said Richard Stonewigg, General Manager at Lachlan Kenya Limited.

The active ingredient of Premise has been approved for use for many years for professional pest control in homes and public buildings.

“The premise has been through a rigorous regulatory evaluation by the government regulator and is safe to people and the environment when the product is used as recommended,” the companies said in a statement.

Read: >>> Bayer Launches New Tomato Variety in Kenya amid US Cancer lawsuit

>>> Bayer pharmacist Dr Anastasia Nyalita retains KAPI Chair position